Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia.
Montanaro A, Kitara S, Cerretani E, Marchesini M, Rompietti C, Pagliaro L, Gherli A, Su A, Minchillo ML, Caputi M, Fioretzaki R, Lorusso B, Ross L, Alexe G, Masselli E, Marozzi M, Rizzi FMA, La Starza R, Mecucci C, Xiong Y, Jin J, Falco A, Knoechel B, Aversa F, Candini O, Quaini F, Sportoletti P, Stegmaier K, Roti G. Montanaro A, et al. Among authors: fioretzaki r. Cell Death Dis. 2022 Jun 17;13(6):551. doi: 10.1038/s41419-022-05002-5. Cell Death Dis. 2022. PMID: 35710782 Free PMC article.
Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives.
Charalampakis N, Tsakatikas S, Schizas D, Kykalos S, Tolia M, Fioretzaki R, Papageorgiou G, Katsaros I, Abdelhakeem AAF, Sewastjanow-Silva M, Rogers JE, Ajani JA. Charalampakis N, et al. Among authors: fioretzaki r. World J Gastrointest Oncol. 2022 Jan 15;14(1):181-202. doi: 10.4251/wjgo.v14.i1.181. World J Gastrointest Oncol. 2022. PMID: 35116110 Free PMC article. Review.
Immunotherapy for cholangiocarcinoma: a 2021 update.
Charalampakis N, Papageorgiou G, Tsakatikas S, Fioretzaki R, Kole C, Kykalos S, Tolia M, Schizas D. Charalampakis N, et al. Among authors: fioretzaki r. Immunotherapy. 2021 Sep;13(13):1113-1134. doi: 10.2217/imt-2021-0126. Epub 2021 Jun 30. Immunotherapy. 2021. PMID: 34190581 Review.
Nivolumab-Induced Guillain-Barré Syndrome Coupled With Remarkable Disease Response in a Case of Heavily Pretreated Lung Adenocarcinoma.
Mazzaschi G, Bordi P, Fioretzaki R, Gnetti L, Milanese G, Tommasi C, Bersanelli M, Roti G, Scoditti U, Leonardi F, Quaini F, Tiseo M. Mazzaschi G, et al. Among authors: fioretzaki r. Clin Lung Cancer. 2020 Mar;21(2):e65-e73. doi: 10.1016/j.cllc.2019.11.001. Epub 2019 Nov 21. Clin Lung Cancer. 2020. PMID: 31837925 No abstract available.